Immediate Impact

60 standout
Sub-graph 1 of 24

Citing Papers

Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
1 intermediate paper

Works of Ann Parker being referenced

First-in-human, Pharmacokinetic and Pharmacodynamic Phase I Study of Resminostat, an Oral Histone Deacetylase Inhibitor, in Patients with Advanced Solid Tumors
2013

Author Peers

Author Last Decade Papers Cites
Ann Parker 146 96 28 81 14 351
Ivan D. Dobrev 175 158 24 84 15 401
Karma C. Fussell 127 88 23 126 22 358
G. Micoli 133 82 20 82 14 358
Esther Vock 76 146 28 129 16 323
Shambhu Roy 70 110 26 110 27 317
R. B. Sleet 144 106 18 92 17 372
Elliott A. Maynard 91 53 12 53 24 325
Miriana S. Machado 77 52 16 116 15 393
Nigel P. Moore 161 93 17 75 33 386
Kazutoshi Shinoda 120 48 49 81 19 323

All Works

Loading papers...

Rankless by CCL
2026